Thomas Mercher

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Ross L. Levine, Martha Wadleigh, Jan Cools et al. · Cancer Cell · 2005 · 3K citations · Full text

Medicine, Genetics, Hematology +14

MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia

Yana Pikman, Benjamin H. Lee, Thomas Mercher et al. · PLoS Medicine · 2006 · 1.4K citations · Full text

Life Sciences, Genetics, Hematology +14

TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis

Cyril Quivoron, Lucile Couronné, Véronique Della Valle et al. · Cancer Cell · 2011 · 897 citations · Full text

Medicine, Hematology, Oncology +10

TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS

Rachel Deplus, Benjamin Delatte, Marie K. Schwinn et al. · The EMBO Journal · 2013 · 489 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +9

Expression of Jak2V617F causes a polycythemia vera–like disease with associated myelofibrosis in a murine bone marrow transplant model

Gerlinde Wernig, Thomas Mercher, Rachel Okabe et al. · Blood · 2006 · 473 citations · Full text

Medicine, Hematology, Pathology +13